Diamyd Medical
@diamyd.com
Diamyd Medical is a swedish clinical-stage diabetes company active in the field of pharmaceutical development. 💙
Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker $DMYD B
www.diamyd.com
Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker $DMYD B
www.diamyd.com
🧬🔬Find out more about ASSET (AI for Sustainable Prevention of Autoimmunity in the Society), a milieu contributing to the development of strategies for personalised prediction and prevention of autoimmune diseases. www.asset.healthcare
Official website for ASSET - AI for Sustainable Prevention of Autoimmunity in the Society
ASSET is an innovation milieu with the aim of developing and evaluating AI algorithms to assess the individual risk of developing type 1 diabetes.
www.asset.healthcare
February 20, 2024 at 2:35 PM
🧬🔬Find out more about ASSET (AI for Sustainable Prevention of Autoimmunity in the Society), a milieu contributing to the development of strategies for personalised prediction and prevention of autoimmune diseases. www.asset.healthcare
Diamyd® is currently being evaluated in the first-ever #precisionmedicine Phase III trial www.DIAGNODE-3.com in individuals recently diagnosed with Type 1 #Diabetes carrying the HLA DR3-DQ2 genotype. #t1d
February 15, 2024 at 10:44 AM
Diamyd® is currently being evaluated in the first-ever #precisionmedicine Phase III trial www.DIAGNODE-3.com in individuals recently diagnosed with Type 1 #Diabetes carrying the HLA DR3-DQ2 genotype. #t1d